Ireland - English - HPRA (Health Products Regulatory Authority)

merck serono limited - metformin hydrochloride - film coated tablet - 500 milligram - biguanides

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - carvedilol, quantity: 6.25 mg - tablet, film coated - excipient ingredients: macrogol 400; magnesium stearate; lactose monohydrate; crospovidone; titanium dioxide; sucrose; polysorbate 80; povidone; colloidal anhydrous silica; hypromellose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - carvedilol, quantity: 3.125 mg - tablet, film coated - excipient ingredients: crospovidone; colloidal anhydrous silica; polysorbate 80; lactose monohydrate; macrogol 400; povidone; sucrose; hypromellose; magnesium stearate; titanium dioxide - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - carvedilol, quantity: 12.5 mg - tablet, film coated - excipient ingredients: titanium dioxide; macrogol 400; crospovidone; magnesium stearate; lactose monohydrate; polysorbate 80; colloidal anhydrous silica; hypromellose; povidone; sucrose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - carvedilol, quantity: 25 mg - tablet, film coated - excipient ingredients: crospovidone; titanium dioxide; magnesium stearate; macrogol 400; polysorbate 80; hypromellose; lactose monohydrate; povidone; colloidal anhydrous silica; sucrose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

strides pharma science pty ltd - carvedilol, quantity: 3.125 mg - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; lactose monohydrate; polysorbate 80; sucrose; colloidal anhydrous silica; macrogol 400; povidone; titanium dioxide; hypromellose - carvedilol is indicated for the treatment of hypertension. data have not been provided to support the use of this drug in renovascular disease.,carvedilol is indicated for the treatment of patients with symptomatic mild to severe (nyha class ii - iv) congestive heart failure (chf) as an adjunct to conventional treatments (e.g. diuretics, digoxin, ace inhibitors and vasodilators).

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - metformin hydrochloride, quantity: 500 mg - tablet, film coated - excipient ingredients: magnesium stearate; hypromellose; povidone - metformin is indicated in the treatment of type 2 diabetes mellitus not satisfactorily controlled by diet, where the risk of lactic acidosis is minimised by excluding predisposing factors, especially impaired renal, hepatic or cardiovascular function. metformin may be used as initial therapy or in sulphonylurea failure, either alone or in combination with a sulphonylurea or as adjuvant therapy in insulin-dependent diabetes.

Malta - English - Medicines Authority

merck sante s.a.s. 37 rue saint romain, 69008 lyon, france - metformin hydrochloride - film-coated tablet - metformin hydrochloride 500 mg - drugs used in diabetes

Malta - English - Medicines Authority

merck sante s.a.s. 37 rue saint romain, 69008 lyon, france - metformin hydrochloride - film-coated tablet - metformin hydrochloride 850 mg - drugs used in diabetes

Ireland - English - HPRA (Health Products Regulatory Authority)

merck serono (ireland) limited - metformin hydrochloride - film-coated tablet - 500 milligram(s) - biguanides; metformin